Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion suggests a new way to classify bradykinin-mediated angio-oedema based on different causes and its possible link with urticaria, which could improve diagnosis and treatment.

Various treatments exist for hair loss, but more research is needed for better options.

Eyelash alopecia areata often goes undiagnosed and can lead to complete eyelash regrowth, especially in younger patients.

Scalp cooling to prevent hair loss from chemotherapy works for some but not all, and studying hair damage markers could improve prevention and treatment.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

Urologic diseases and treatments in older men can negatively affect fertility, and doctors should talk to patients about this.

Camouflaging agents like hair fibers and wigs significantly improve appearance and self-esteem for most hair loss patients.

Several new treatments for different types of hair loss show promise in improving patient quality of life.

New acne treatments include combination creams, advanced retinoids, and light therapies, focusing on safety and patient adherence.

Combining baricitinib with UV-B therapy effectively treats non-segmental vitiligo and is well-tolerated.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

More research is needed on alopecia areata treatments and its psychological effects.

Early treatment of acne is crucial to prevent scarring and psychological effects.

More research is needed to find the best treatment for dissecting cellulitis of the scalp.

Apremilast shows promise for several skin conditions but needs more research.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Baricitinib is a promising treatment for alopecia areata in the UAE, but there are challenges with data and access.

De nouvelles thérapies promettent de mieux traiter la perte de cheveux due à l'alopécie androgénétique.

Janus kinase inhibitors effectively treat alopecia areata but may cause relapses and have long-term safety concerns.

JAK inhibitors show promise for treating skin diseases effectively and safely.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

There are significant gaps and inconsistencies in diagnosing and treating alopecia areata in Greece and Italy.

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.

Encapsulating hair loss drugs in cyclodextrins improves their solubility and reduces scalp irritation.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

Up to half of people experience itchy scalp, often due to skin conditions like seborrheic dermatitis or psoriasis, and treatments vary based on the specific cause.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Microneedling may improve melasma treatment by boosting topical therapy effectiveness.

Hair transplants can rarely cause scalp inflammation leading to hair loss, needing early detection and treatment.